David P. Astling

1.6k total citations
24 papers, 900 citations indexed

About

David P. Astling is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David P. Astling has authored 24 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David P. Astling's work include Genomic variations and chromosomal abnormalities (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). David P. Astling is often cited by papers focused on Genomic variations and chromosomal abnormalities (4 papers), Bacterial Genetics and Biotechnology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). David P. Astling collaborates with scholars based in United States, Qatar and Germany. David P. Astling's co-authors include Aik Choon Tan, Lynn E. Heasley, Trista K. Hinz, David R. Zusman, Emily K. Kleczko, B. Helfrich, Lindsay A. Marek, Douglas K. Graham, Christopher T. Cummings and Katherine R. Singleton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

David P. Astling

24 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David P. Astling United States	15	591	228	224	154	97	24	900
Eric P. Rahrmann United States	15	613 1.0×	185 0.8×	129 0.6×	121 0.8×	134 1.4×	27	1.0k
Geeta Upadhyay United States	16	596 1.0×	209 0.9×	266 1.2×	104 0.7×	167 1.7×	31	1.2k
Takeshi Namiki Japan	13	460 0.8×	129 0.6×	194 0.9×	99 0.6×	134 1.4×	58	1.0k
Vincenzo Di Majo Italy	19	562 1.0×	339 1.5×	208 0.9×	108 0.7×	113 1.2×	49	1.2k
Teresa T. Nguyen United States	15	448 0.8×	164 0.7×	398 1.8×	159 1.0×	172 1.8×	34	951
Markus Morkel Germany	21	1.0k 1.7×	167 0.7×	420 1.9×	176 1.1×	262 2.7×	33	1.6k
Yifat S. Oren Israel	14	1.2k 2.0×	242 1.1×	263 1.2×	202 1.3×	166 1.7×	17	1.5k
Jill M. Keller United States	18	619 1.0×	364 1.6×	464 2.1×	53 0.3×	227 2.3×	30	1.1k
Sebastian Patzke Norway	21	756 1.3×	116 0.5×	250 1.1×	224 1.5×	117 1.2×	36	1.0k
Meiying Li China	18	236 0.4×	131 0.6×	209 0.9×	57 0.4×	96 1.0×	43	752

Countries citing papers authored by David P. Astling

Since Specialization

Citations

This map shows the geographic impact of David P. Astling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Astling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Astling more than expected).

Fields of papers citing papers by David P. Astling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Astling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Astling. The network helps show where David P. Astling may publish in the future.

Co-authorship network of co-authors of David P. Astling

This figure shows the co-authorship network connecting the top 25 collaborators of David P. Astling. A scholar is included among the top collaborators of David P. Astling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Astling. David P. Astling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schneider, Daniel J., Clare Paterson, Matthew J. Westacott, et al.. (2024). Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the Proteome. Journal of Proteome Research. 23(11). 4771–4788. 9 indexed citations

Sattar, Naveed, Shahrad Taheri, David P. Astling, et al.. (2023). Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission. Diabetes Care. 46(11). 1949–1957. 7 indexed citations

Yilmaz, Feyza, David P. Astling, Hung‐Chun Yu, et al.. (2021). Genome-wide analysis of copy number variants and normal facial variation in a large cohort of Bantu Africans. SHILAP Revista de lepidopterología. 3(1). 100082–100082. 2 indexed citations

Yilmaz, Feyza, David P. Astling, Hung‐Chun Yu, et al.. (2021). Genome-wide copy number variations in a large cohort of bantu African children. BMC Medical Genomics. 14(1). 129–129. 7 indexed citations

Wolk, Steven K., Amy D. Gelinas, David P. Astling, et al.. (2020). Modified nucleotides may have enhanced early RNA catalysis. Proceedings of the National Academy of Sciences. 117(15). 8236–8242. 21 indexed citations

Kowarik, Markus C., David P. Astling, Gildas Lepennetier, et al.. (2020). Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients. Neurotherapeutics. 18(1). 364–377. 22 indexed citations

Knoshaug, Eric P., et al.. (2020). Draft Genome Sequence of the Biofuel-Relevant Microalga Desmodesmus armatus. Microbiology Resource Announcements. 9(6). 9 indexed citations

Kogut, Igor, David P. Astling, Xiaomi Chen, et al.. (2018). High-efficiency RNA-based reprogramming of human primary fibroblasts. Nature Communications. 9(1). 745–745. 115 indexed citations

Dodson, R. Blair, Jason Gien, Paul J. Rozance, et al.. (2018). Intrauterine growth restriction decreases NF-κB signaling in fetal pulmonary artery endothelial cells of fetal sheep. American Journal of Physiology-Lung Cellular and Molecular Physiology. 315(3). L348–L359. 14 indexed citations

10.

Astling, David P., et al.. (2017). High resolution measurement of DUF1220 domain copy number from whole genome sequence data. BMC Genomics. 18(1). 614–614. 14 indexed citations

11.

Astling, David P., Rie Matsumi, Brett W. Burkhart, et al.. (2017). Genome Replication in Thermococcus kodakarensis Independent of Cdc6 and an Origin of Replication. Frontiers in Microbiology. 8. 2084–2084. 25 indexed citations

12.

Kowarik, Markus C., David P. Astling, Christiane Gasperi, et al.. (2017). CNS Aquaporin‐4‐specific B cells connect with multiple B‐cell compartments in neuromyelitis optica spectrum disorder. Annals of Clinical and Translational Neurology. 4(6). 369–380. 52 indexed citations

13.

Bowles, Daniel W., Jennifer R. Diamond, Elaine T. Lam, et al.. (2014). Phase I Study of Oral Rigosertib (ON 01910.Na), a Dual Inhibitor of the PI3K and Plk1 Pathways, in Adult Patients with Advanced Solid Malignancies. Clinical Cancer Research. 20(6). 1656–1665. 54 indexed citations

14.

O’Bleness, Majesta, C. Michael Dickens, David P. Astling, et al.. (2014). Finished sequence and assembly of the DUF1220-rich 1q21 region using a haploid human genome. BMC Genomics. 15(1). 387–387. 35 indexed citations

15.

Subramanian, Venkataramanan, Alexandra Dubini, David P. Astling, et al.. (2014). ProfilingChlamydomonasMetabolism under Dark, Anoxic H₂-Producing Conditions Using a Combined Proteomic, Transcriptomic, and Metabolomic Approach. Journal of Proteome Research. 13(12). 5431–5451. 17 indexed citations

16.

Anderson, Ryan T., Stephen B. Keysar, Daniel W. Bowles, et al.. (2013). The Dual Pathway Inhibitor Rigosertib Is Effective in Direct Patient Tumor Xenografts of Head and Neck Squamous Cell Carcinomas. Molecular Cancer Therapeutics. 12(10). 1994–2005. 20 indexed citations

17.

Hinz, Trista K., Emily K. Kleczko, Katherine R. Singleton, et al.. (2013). A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop. Oncogenesis. 2(3). e39–e39. 203 indexed citations

18.

Davies, Kurtis D., David P. Astling, Dara L. Aisner, et al.. (2013). Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer. PLoS ONE. 8(12). e82236–e82236. 104 indexed citations

19.

Giles, Erin D., Elizabeth A. Wellberg, David P. Astling, et al.. (2012). Obesity and Overfeeding Affecting Both Tumor and Systemic Metabolism Activates the Progesterone Receptor to Contribute to Postmenopausal Breast Cancer. Cancer Research. 72(24). 6490–6501. 50 indexed citations

20.

Ward, Mandy J., Kenny C. Mok, David P. Astling, Helen Lew, & David R. Zusman. (1998). An ABC Transporter Plays a Developmental Aggregation Role in Myxococcus xanthus. Journal of Bacteriology. 180(21). 5697–5703. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact